PRKCB and neoplasm: We saw no measurable difference in tumor vascularization, as measured by MECA-32 staining, between the Prkcb−/− and WT groups (Figure 2C), demonstrating that the delayed tumor onset and growth observed in Prkcb−/− mice was independent of vasculature formation.